Details
Stereochemistry | ACHIRAL |
Molecular Formula | C2H6O |
Molecular Weight | 46.0684 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCO
InChI
InChIKey=LFQSCWFLJHTTHZ-UHFFFAOYSA-N
InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3
Molecular Formula | C2H6O |
Molecular Weight | 46.0684 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/9880479Curator's Comment: description was created based on several sources, including
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021074Orig1s010lbl.pdf
https://www.ncbi.nlm.nih.gov/pubmed/17591544
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9880479
Curator's Comment: description was created based on several sources, including
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021074Orig1s010lbl.pdf
https://www.ncbi.nlm.nih.gov/pubmed/17591544
Alcohols exhibit rapid broad-spectrum antimicrobial activity against vegetative bacteria (including mycobacteria), viruses, and fungi but are not sporicidal. They are, however, known to inhibit sporulation and spore germination, but this effect is reversible. Because of the lack of sporicidal activity, alcohols are not recommended for sterilization but are widely used for both hard-surface disinfection and skin antisepsis. Lower concentrations may also be used as preservatives and to potentiate the activity of other biocides. Many alcohol products include low levels of other biocides (in particular chlorhexidine), which remain on the skin following evaporation of the alcohol, or excipients (including emollients), which decrease the evaporation time of the alcohol and can significantly increase product efficacy. Ethanol in combination with: chlorhexidine gluconate 1% was approved to use in surgical hand antiseptic. It significantly reduces the number of microorganisms on the hands and forearms prior to surgery or patient care. Ethanol is also used as a co-solvent to dissolve many insoluble drugs and to serve as a mild sedative in some medicinal formulations. Ethanol is metabolized by the hepatic enzyme alcohol dehydrogenase. Ethanol affects the brain’s neurons in several ways. It alters their membranes as well as their ion channels, enzymes, and receptors. Alcohol also binds directly to the receptors for acetylcholine, serotonin, GABA, and the NMDA receptors for glutamate. The sedative effects of ethanol are mediated through binding to GABA receptors and glycine receptors (alpha 1 and alpha 2 subunits). It also inhibits NMDA receptor functioning. In its role as an anti-infective, ethanol acts as an osmolyte or dehydrating agent that disrupts the osmotic balance across cell membranes.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1962 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17591544 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | AVAGARD Approved UseSurgical hand antiseptic: Significantly reduces the number of micro-organisms on the hands and forearms prior to surgery or patient care Launch Date2001 |
PubMed
Title | Date | PubMed |
---|---|---|
Central leptin and cholecystokinin in gastroprotection against ethanol-induced damage. | 2000 |
|
Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen. | 2000 Dec 8 |
|
Rhabdomyolysis and drugs of abuse. | 2000 Jul |
|
Enhanced urinary excretion of cysteinyl leukotrienes in patients with acute alcohol intoxication. | 2000 Jun |
|
Acute ethanol decreases NPY mRNA but not POMC mRNA in the arcuate nucleus. | 2000 Nov 9 |
|
Short-term treatment with alcohols causes hepatic steatosis and enhances acetaminophen hepatotoxicity in Cyp2e1(-/-) mice. | 2000 Oct 15 |
|
Inducers of gamma-glutamylcysteine synthetase and their effects on glutathione synthetase expression. | 2000 Sep 7 |
|
Risk factors for pancreatic cancer: a case-control study based on direct interviews. | 2001 |
|
Staining and measurement of DNA in bacteria. | 2001 |
|
Prediction of Fenton oxidation positions in polycyclic aromatic hydrocarbons by Frontier electron density. | 2001 Feb |
|
Bacterial release of arsenic ions and organoarsenic compounds from soil contaminated by chemical warfare agents. | 2001 Feb |
|
Phosphatidic acid regulates tyrosine phosphorylating activity in human neutrophils: enhancement of Fgr activity. | 2001 Feb 16 |
|
A novel alcohol oxidase/RNA-binding protein with affinity for mycovirus double-stranded RNA from the filamentous fungus Helminthosporium (Cochliobolus) victoriae: molecular and functional characterization. | 2001 Feb 16 |
|
Intracellular fluxes in a recombinant xylose-utilizing Saccharomyces cerevisiae cultivated anaerobically at different dilution rates and feed concentrations. | 2001 Feb 5 |
|
Adenovirus-mediated overexpression of catalase in the cytosolic or mitochondrial compartment protects against cytochrome P450 2E1-dependent toxicity in HepG2 cells. | 2001 Feb 9 |
|
Peroxisomal remnant structures in Hansenula polymorpha Pex5 cells can develop into normal peroxisomes upon induction of the PTS2 protein amine oxidase. | 2001 Feb 9 |
|
Patients admitted to emergency services for drunkenness: moderate alcohol users or harmful drinkers? | 2001 Jan |
|
The efficacy of esmolol versus lidocaine to attenuate the hemodynamic response to intubation in isolated head trauma patients. | 2001 Jan |
|
Selected in-treatment outcomes of long-term methadone maintenance treatment patients in New York State. | 2001 Jan |
|
Integrating the methadone patient in the traditional addiction inpatient rehabilitation program--problems and solutions. | 2001 Jan |
|
Severe ethylene glycol ingestion treated without hemodialysis. | 2001 Jan |
|
Fomepizole in the treatment of poisoning. | 2001 Jan |
|
Major changes in human ocular UV protection with age. | 2001 Jan |
|
Inhibition of CYP2E1 with natural agents may be a feasible strategy for minimizing the hepatotoxicity of ethanol. | 2001 Jan |
|
Up-regulation of hepatic IGFBP-1 production as a strategy for preventing benign prostatic hyperplasia. | 2001 Jan |
|
Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. | 2001 Jan |
|
Ethanol acts synergistically with a D2 dopamine agonist to cause translocation of protein kinase C. | 2001 Jan |
|
Outcome of hospital care of liver disease associated with hepatitis C in the United States. | 2001 Jan |
|
Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats. | 2001 Jan |
|
A single bout of exercise induces beta-adrenergic desensitization in human adipose tissue. | 2001 Jan |
|
Induction of ppGpp synthesis in Streptomyces coelicolor A3(2) grown under conditions of nutritional sufficiency elicits actII-ORF4 transcription and actinorhodin biosynthesis. | 2001 Jan |
|
Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. | 2001 Jan |
|
Ethanol potentiation of glycine-induced responses in dissociated neurons of rat ventral tegmental area. | 2001 Jan |
|
Evaluation of surgical excision of non-homogeneous oral leukoplakia in a screening intervention trial, Kerala, India. | 2001 Jan |
|
Smoking and alcohol in the etiology of oral cancer: gender-specific risk profiles in the south of Greece. | 2001 Jan |
|
Optimizing the sterilization of PLGA scaffolds for use in tissue engineering. | 2001 Jan |
|
Effect of short-term ethanol administration on cadmium excretion in rats. | 2001 Jan |
|
Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant. | 2001 Jan |
|
Metal-catalyzed oxidation of human growth hormone: modulation by solvent-induced changes of protein conformation. | 2001 Jan |
|
Caffeine dissociates complexes between DNA and intercalating dyes: application for bleaching fluorochrome-stained cells for their subsequent restaining and analysis by laser scanning cytometry. | 2001 Jan 1 |
|
On the diagnosis of hypoglycemia in car drivers--including a review of the literature. | 2001 Jan 1 |
|
Efficient regression calibration for logistic regression in main study/internal validation study designs with an imperfect reference instrument. | 2001 Jan 15 |
|
Expression of a cytoplasmic transhydrogenase in Saccharomyces cerevisiae results in formation of 2-oxoglutarate due to depletion of the NADPH pool. | 2001 Jan 15 |
|
The transcriptional activator Cat8p provides a major contribution to the reprogramming of carbon metabolism during the diauxic shift in Saccharomyces cerevisiae. | 2001 Jan 5 |
|
Laryngeal carcinoma--epidemiological and clinical features: experience of the Rabin Medical Center in Israel. | 2001 Jan-Feb |
|
On the enzymatic activation of NADH. | 2001 Mar 23 |
|
Regulation of the aldehyde dehydrogenase gene (aldA) and its role in the control of the coinducer level necessary for induction of the ethanol utilization pathway in Aspergillus nidulans. | 2001 Mar 9 |
|
Improved resistance to transition metals of a cobalt-substituted alcohol dehydrogenase 1 from Saccharomyces cerevisiae. | 2001 Nov 17 |
|
Continuous enantioselective esterification of trans-2-phenyl-1-cyclohexanol using a new Candida rugosa lipase in a packed bed bioreactor. | 2001 Nov 17 |
|
Increased production of human proinsulin in the periplasmic space of Escherichia coli by fusion to DsbA. | 2001 Nov 30 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27679397
Primary cultures of cortical neurons obtained from 1-day-old rats were exposed to EtOH after 7days of culture, and viability and morphology were analyzed at structural and ultrastructural levels after 24-h EtOH exposure. EtOH caused a significant reduction of 73±7% in the viability of cultured cortical neurons, by preferentially inducing apoptotic cellular death. This effect was accompanied by an increase in caspase 3 and 9 expression. EtOH induced a reduction in total dendrite length and in the number of dendrites per cell. Ultrastructural studies showed that EtOH increased the number of lipidic vacuoles, lysosomes and multilamellar vesicles and induced a dilated endoplasmatic reticulum lumen and a disorganized Golgi apparatus with a ring-shape appearance. Microtubules showed a disorganized distribution
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:16:07 GMT 2023
by
admin
on
Fri Dec 15 15:16:07 GMT 2023
|
Record UNII |
3K9958V90M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 184.1293
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
15.1
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-VATC |
QV03AB16
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
CFR |
21 CFR 862.3050
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
402513
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
EPA PESTICIDE CODE |
1501
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
V03AB16
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-VATC |
QV03AZ01
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
212205
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
361611
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
DSLD |
1152 (Number of products:173)
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-VATC |
QD08AX08
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
212505
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
D08AX08
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/04/191
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
CFR |
21 CFR 862.3040
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
V03AZ01
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
JECFA EVALUATION |
ETHANOL
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
DSLD |
291 (Number of products:2)
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
FDA ORPHAN DRUG |
746720
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
WHO-ATC |
D08AX08
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
NCI_THESAURUS |
C218
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
||
|
CFR |
21 CFR 328.10
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB00898
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
16236
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
3K9958V90M
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
CHEMBL545
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
100000078985
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
C2190
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
SUB11947MIG
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
1310469
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
ALTERNATIVE | |||
|
1076
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
3K9958V90M
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
448
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
64-17-5
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
200-578-6
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
m11495
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
8024-45-1
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
SUPERSEDED | |||
|
8000-16-6
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
SUPERSEDED | |||
|
ALCOHOL, DEHYDRATED
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Description: A colourless, clear and mobile liquid; odour, characteristic.Miscibility: Miscible with water and ether R.Category: Solvent; antiseptic.Storage: Ethanol should be kept in a well-closed container, and stored whenever possible at a temperature between 8 and 15 ?C.Additional information: Ethanol is flammable, burning with a blue smokeless flame. Hygroscopic. Boiling point, about 79 ?C.Requirement: Ethanol contains not less than 98.8% v/v and not more than the equivalent of 100.0% v/v of C2H6O, corresponding to not less than 98.1% m/m and not more than the equivalent of 100.0% m/mof C2H6O. | ||
|
Alcohol
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
SUB13730MIG
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
m5084
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Merck Index | ||
|
ETHANOL
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
D000431
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
702
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
SUB125851
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
ALTERNATIVE | |||
|
30879
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
1012772
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | |||
|
ALCOHOL
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY | Description: A clear, colourless, and mobile liquid; odour, characteristic. Miscibility: Miscible with water, ether R, and glycerol R. Category: Solvent; antiseptic. Storage: Alcohol should be kept in a well-closed container, and stored whenever possible at a temperature between 8 and 15 ?C. Labelling: The designation on the container should state the content of Alcohol in % v/v. Additional information: Different concentrations of Alcohol are prepared from alcohol 96% v/v and water at about 20 ?C.Note: Contraction of volume and rise in temperature occur when mixing Alcohol with water. | ||
|
151
Created by
admin on Fri Dec 15 15:16:07 GMT 2023 , Edited by admin on Fri Dec 15 15:16:07 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> INDUCER |
CLINICALLY SIGNIFICANT
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
|
||
|
METABOLITE TOXIC -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|